1
|
Wu S, Dong T, Li Y, Sun M, Qi Y, Liu J, Kuss MA, Chen S, Duan B. State-of-the-art review of advanced electrospun nanofiber yarn-based textiles for biomedical applications. Appl Mater Today 2022; 27:101473. [PMID: 35434263 PMCID: PMC8994858 DOI: 10.1016/j.apmt.2022.101473] [Citation(s) in RCA: 37] [Impact Index Per Article: 18.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/04/2022] [Revised: 03/23/2022] [Accepted: 03/31/2022] [Indexed: 05/02/2023]
Abstract
The pandemic of the coronavirus disease 2019 (COVID-19) has made biotextiles, including face masks and protective clothing, quite familiar in our daily lives. Biotextiles are one broad category of textile products that are beyond our imagination. Currently, biotextiles have been routinely utilized in various biomedical fields, like daily protection, wound healing, tissue regeneration, drug delivery, and sensing, to improve the health and medical conditions of individuals. However, these biotextiles are commonly manufactured with fibers with diameters on the micrometer scale (> 10 μm). Recently, nanofibrous materials have aroused extensive attention in the fields of fiber science and textile engineering because the fibers with nanoscale diameters exhibited obviously superior performances, such as size and surface/interface effects as well as optical, electrical, mechanical, and biological properties, compared to microfibers. A combination of innovative electrospinning techniques and traditional textile-forming strategies opens a new window for the generation of nanofibrous biotextiles to renew and update traditional microfibrous biotextiles. In the last two decades, the conventional electrospinning device has been widely modified to generate nanofiber yarns (NYs) with the fiber diameters less than 1000 nm. The electrospun NYs can be further employed as the primary processing unit for manufacturing a new generation of nano-textiles using various textile-forming strategies. In this review, starting from the basic information of conventional electrospinning techniques, we summarize the innovative electrospinning strategies for NY fabrication and critically discuss their advantages and limitations. This review further covers the progress in the construction of electrospun NY-based nanotextiles and their recent applications in biomedical fields, mainly including surgical sutures, various scaffolds and implants for tissue engineering, smart wearable bioelectronics, and their current and potential applications in the COVID-19 pandemic. At the end, this review highlights and identifies the future needs and opportunities of electrospun NYs and NY-based nanotextiles for clinical use.
Collapse
Key Words
- CNT, carbon nanotube
- COVID-19, coronavirus disease 2019
- ECM, extracellular matrix
- Electrospinning
- FDA, food and drug administration
- GF, gauge factor
- GO, graphene oxide
- HAVIC, human aortic valve interstitial cell
- HAp, hydroxyapatite
- MSC, mesenchymal stem cell
- MSC-SC, MSC derived Schwann cell-like cell
- MWCNT, multiwalled carbon nanotube
- MY, microfiber yarn
- MeGel, methacrylated gelatin
- NGC, nerve guidance conduit
- NHMR, neutral hollow metal rod
- NMD, neutral metal disc
- NY, nanofiber yarn
- Nanoyarns
- PA6, polyamide 6
- PA66, polyamide 66
- PAN, polyacrylonitrile
- PANi, polyaniline
- PCL, polycaprolactone
- PEO, polyethylene oxide
- PGA, polyglycolide
- PHBV, poly(3-hydroxybutyrate-co-3-hydroxyvalerate)
- PLCL, poly(L-lactide-co-ε-caprolactone)
- PLGA, poly(lactic-co-glycolic acid)
- PLLA, poly(L-lactic acid)
- PMIA, poly(m-phenylene isophthalamide)
- PPDO, polydioxanone
- PPy, polypyrrole
- PSA, poly(sulfone amide)
- PU, polyurethane
- PVA, poly(vinyl alcohol)
- PVAc, poly(vinyl acetate)
- PVDF, poly(vinylidene difluoride)
- PVDF-HFP, poly(vinylidene floride-co-hexafluoropropylene)
- PVDF-TrFE, poly(vinylidene fluoride trifluoroethylene)
- PVP, poly(vinyl pyrrolidone)
- SARS-CoV-2, severe acute respiratory syndrome coronavirus 2
- SC, Schwann cell
- SF, silk fibroin
- SWCNT, single-walled carbon nanotube
- TGF-β1, transforming growth factor-β1
- Textile-forming technique
- Tissue scaffolds
- VEGF, vascular endothelial growth factor
- Wearable bioelectronics
- bFGF, basic fibroblast growth factor
Collapse
Affiliation(s)
- Shaohua Wu
- College of Textiles & Clothing, Qingdao University, Qingdao, China
| | - Ting Dong
- College of Textiles & Clothing, Qingdao University, Qingdao, China
| | - Yiran Li
- College of Textiles & Clothing, Qingdao University, Qingdao, China
| | - Mingchao Sun
- College of Textiles & Clothing, Qingdao University, Qingdao, China
| | - Ye Qi
- College of Textiles & Clothing, Qingdao University, Qingdao, China
| | - Jiao Liu
- College of Textiles & Clothing, Qingdao University, Qingdao, China
| | - Mitchell A Kuss
- Mary & Dick Holland Regenerative Medicine Program and Division of Cardiology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA
- Department of Surgery, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA
| | - Shaojuan Chen
- College of Textiles & Clothing, Qingdao University, Qingdao, China
| | - Bin Duan
- Mary & Dick Holland Regenerative Medicine Program and Division of Cardiology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA
- Department of Surgery, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA
| |
Collapse
|
2
|
Oveissi F, Naficy S, Lee A, Winlaw D, Dehghani F. Materials and manufacturing perspectives in engineering heart valves: a review. Mater Today Bio 2020; 5:100038. [PMID: 32211604 PMCID: PMC7083765 DOI: 10.1016/j.mtbio.2019.100038] [Citation(s) in RCA: 38] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2019] [Revised: 11/26/2019] [Accepted: 11/27/2019] [Indexed: 12/27/2022] Open
Abstract
Valvular heart diseases (VHD) are a major health burden, affecting millions of people worldwide. The treatments for such diseases rely on medicine, valve repair, and artificial heart valves including mechanical and bioprosthetic valves. Yet, there are countless reports on possible alternatives noting long-term stability and biocompatibility issues and highlighting the need for fabrication of more durable and effective replacements. This review discusses the current and potential materials that can be used for developing such valves along with existing and developing fabrication methods. With this perspective, we quantitatively compare mechanical properties of various materials that are currently used or proposed for heart valves along with their fabrication processes to identify challenges we face in creating new materials and manufacturing techniques to better mimick the performance of native heart valves.
Collapse
Key Words
- 3D printing
- Biofabrication
- Biomaterials
- E, Young's modulus
- Electrospinning
- Gal, galactose-α1,3-galactose
- GelMa, gelatin methacrylate
- HA, hyaluronic acid
- HAVIC, human aortic valvular interstitial cells
- MA-HA, methacrylated hyaluronic acid
- NeuGc, N-glycolylneuraminic acid
- P4HB, poly(4-hydroxybutyrate)
- PAAm, polyacrylamide
- PCE, polycitrate-(ε-polypeptide)
- PCL, polycaprolactone
- PE, polyethylene
- PEG, polyethylene glycol
- PEGDA, polyethylene glycol diacrylate
- PGA, poly(glycolic acid)
- PHA, poly(hydroxyalkanoate)
- PLA, polylactide
- PMMA, poly(methyl methacrylate)
- PPG, polypropylene glycol
- PTFE, polytetrafluoroethylene
- PU, polyurethane
- SIBS, poly(styrene-b-isobutylene-b-styrene)
- SMC, smooth muscle cells
- VHD, valvular heart disease
- VIC, aortic valve leaflet interstitial cells
- Valvular heart diseases
- dECM, decellularized extracellular matrix
- ePTFE, expanded PTFE
- xSIBS, crosslinked version of SIBS
- α-SMA, alpha-smooth muscle actin
Collapse
Affiliation(s)
- F. Oveissi
- School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, New South Wales, 2006, Australia
| | - S. Naficy
- School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, New South Wales, 2006, Australia
| | - A. Lee
- School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, New South Wales, 2006, Australia
- Discipline of Child and Adolescent Health, Sydney Medical School, Faculty of Health and Medicine, The University of Sydney, New South Wales, 2006, Australia
- Heart Centre for Children, The Children's Hospital at Westmead, New South Wales, 2145, Australia
| | - D.S. Winlaw
- Discipline of Child and Adolescent Health, Sydney Medical School, Faculty of Health and Medicine, The University of Sydney, New South Wales, 2006, Australia
- Heart Centre for Children, The Children's Hospital at Westmead, New South Wales, 2145, Australia
| | - F. Dehghani
- School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, New South Wales, 2006, Australia
| |
Collapse
|
3
|
Chen X, Liu L, Jiang C. Charge-reversal nanoparticles: novel targeted drug delivery carriers. Acta Pharm Sin B 2016; 6:261-7. [PMID: 27471667 PMCID: PMC4951588 DOI: 10.1016/j.apsb.2016.05.011] [Citation(s) in RCA: 67] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2016] [Revised: 05/15/2016] [Accepted: 05/16/2016] [Indexed: 01/31/2023] Open
Abstract
Spurred by significant progress in materials chemistry and drug delivery, charge-reversal nanocarriers are being developed to deliver anticancer formulations in spatial-, temporal- and dosage-controlled approaches. Charge-reversal nanoparticles can release their drug payload in response to specific stimuli that alter the charge on their surface. They can elude clearance from the circulation and be activated by protonation, enzymatic cleavage, or a molecular conformational change. In this review, we discuss the physiological basis for, and recent advances in the design of charge-reversal nanoparticles that are able to control drug biodistribution in response to specific stimuli, endogenous factors (changes in pH, redox gradients, or enzyme concentration) or exogenous factors (light or thermos-stimulation).
Collapse
Key Words
- Abs, integrin aVb3 mAbs
- B-PDEAEA, poly[(2-acryloyl) ethyl (p-boronic acid benzyl) diethylammonium bromide]
- BPS, bridged polysilsesquioxanexerogel
- BSA, bovine serum albumin
- CA4, combretastatin A4
- CAPL, charge reversible pullulan-based
- CHPNH2, cationic cholesteryl group–bearing pullulans
- CMC, carboxymethyl cellulose
- CPLAs, cationic polylactides
- Cancer therapy
- Charge-reversal nanoparticles
- Cit, citraconic anhydride
- Cya, cysteamine hydrochloride
- DAP, 2,3-diamino-propionate
- DCL, dimethyl maleamidic acid-ε-caprolactone
- DDS, drug delivery system
- DM, dimyristeroyl
- DMA, 2,3-dimethylmaleic anhydride
- DMPA, dimethylol propionic acid
- DOX, doxorubicin
- Drug delivery carriers
- FITC, fluorescein isothiocyanate
- GO, graphene oxide
- GSH, glutathione
- Glu, glutamic acid
- HCC, hepatocellular carcinoma
- HEP, 1,4-bis(2-hydroxyethyl) piperazine
- HMP, p-hydroxylmethylenephenol
- His, histidine
- MG, microgels
- MMPs, matrix metalloproteinases
- MNP, magnetic nanoparticles
- NPs, nanoparticles
- Nanotechnology
- PAEP, poly(allyl ethylene phosphate)
- PAH, poly(allylamine) hydrochloride
- PBAE, poly(β-amino ester)
- PCL, poly(ε-caprolactone)
- PDADMAC, poly(diallyldimethylammonium chloride)
- PEG, polyethylene glycol
- PEI, polyethylenimine
- PEO, poly(ethylene oxide)
- PK, protein kinase
- PLA, ploylactic acid
- PLGA, poly(lactic-co-glycolic acid)
- PLL, poly(l-lysine)
- PMA, poly(methacrylic acid)
- PS, pH sensitive
- PSS, poly(sodium 4-styrenesulfonate)
- PSSS, poly(styrene-co-4-styrene-sulfonate)
- PTX, paclitaxel
- PU, polyurethane
- PVPON, poly(N-vinylpyrrolidone)
- ROS, reactive oxygen species
- SOD, superoxide dismutase
- Stimuli responsive
- TMA, 2-(mercaptoethyl) trimethylammonium chloride
- TUNA, thioundecyl-tetraethyleneglycolester-o-nitrobenzy-lethyldimethyl ammonium bromide
- pA-F, fluorescein-labeled polyanion
Collapse
Affiliation(s)
- Xinli Chen
- Key Laboratory of Smart Drug Delivery, Ministry of Education, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China
| | - Lisha Liu
- Key Laboratory of Smart Drug Delivery, Ministry of Education, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China
| | - Chen Jiang
- Key Laboratory of Smart Drug Delivery, Ministry of Education, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China
- State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai 200032, China
| |
Collapse
|